New coumarin derivatives as carbonic anhydrase inhibitors
dc.authorid | Karataş, Mert Olgun/0000-0001-8500-2088 | |
dc.authorid | Gençer, Nahit/0000-0001-7092-8857 | |
dc.authorid | Gençer, Nahit/0000-0001-7092-8857 | |
dc.authorid | Ergün, Adem/0000-0003-4647-6058 | |
dc.authorid | ALICI, Bulent/0000-0001-5009-3223 | |
dc.authorwosid | Karataş, Mert Olgun/ABG-7848-2020 | |
dc.authorwosid | Gençer, Nahit/HHD-1544-2022 | |
dc.authorwosid | Gençer, Nahit/AAG-4507-2019 | |
dc.authorwosid | Ergün, Adem/AAC-1751-2022 | |
dc.authorwosid | ALICI, Bulent/AAG-4203-2019 | |
dc.contributor.author | Karatas, Mert Olgun | |
dc.contributor.author | Alici, Bulent | |
dc.contributor.author | Cakir, Umit | |
dc.contributor.author | Cetinkaya, Engin | |
dc.contributor.author | Demir, Dudu | |
dc.contributor.author | Ergun, Adem | |
dc.contributor.author | Gencer, Nahit | |
dc.date.accessioned | 2024-08-04T20:39:42Z | |
dc.date.available | 2024-08-04T20:39:42Z | |
dc.date.issued | 2014 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | In the current study, a series of 4-chloromethyl-7-hydroxy-coumarin derivatives containing imidazolium, benzimidazolium, bisbenzimidazolium and quaternary ammonium salts were synthesized, characterized and the inhibition effects of the derivatives on human carbonic anhydrases (hCA I and hCA II) were investigated as in vitro. Structures of these coumarins were confirmed by FT-IR, (1)H NMR, (13)C NMR and LC-MS analyses. Structure activity relationship study showed that 3d (IC50: 79 mu m M for hCA I and 88 m M for hCA II) performed higher inhibitory activity than others. | en_US |
dc.identifier.doi | 10.3109/21691401.2013.794352 | |
dc.identifier.endpage | 198 | en_US |
dc.identifier.issn | 2169-1401 | |
dc.identifier.issn | 2169-141X | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 23656671 | en_US |
dc.identifier.scopus | 2-s2.0-84901012639 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 192 | en_US |
dc.identifier.uri | https://doi.org/10.3109/21691401.2013.794352 | |
dc.identifier.uri | https://hdl.handle.net/11616/96452 | |
dc.identifier.volume | 42 | en_US |
dc.identifier.wos | WOS:000336498100006 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Artificial Cells Nanomedicine and Biotechnology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | benzimidazolium | en_US |
dc.subject | carbonic anhydrase | en_US |
dc.subject | coumarin | en_US |
dc.subject | imidazolium | en_US |
dc.subject | inhibition | en_US |
dc.title | New coumarin derivatives as carbonic anhydrase inhibitors | en_US |
dc.type | Article | en_US |